Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to $190000.0.

  • Aytu Biopharma's Non Operating Income rose 3571.43% to $190000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$803000.0, marking a year-over-year decrease of 19208.72%. This contributed to the annual value of -$512000.0 for FY2025, which is 15885.06% down from last year.
  • Aytu Biopharma's Non Operating Income amounted to $190000.0 in Q4 2025, which was up 3571.43% from $201000.0 recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Non Operating Income ranged from a high of $3.7 million in Q2 2023 and a low of -$1.2 million during Q2 2025
  • Moreover, its 5-year median value for Non Operating Income was $125000.0 (2022), whereas its average is $280350.0.
  • As far as peak fluctuations go, Aytu Biopharma's Non Operating Income surged by 52741.31% in 2022, and later plummeted by 112500.0% in 2025.
  • Over the past 5 years, Aytu Biopharma's Non Operating Income (Quarter) stood at -$257000.0 in 2021, then crashed by 377.82% to -$1.2 million in 2022, then surged by 107.82% to $96000.0 in 2023, then surged by 45.83% to $140000.0 in 2024, then soared by 35.71% to $190000.0 in 2025.
  • Its Non Operating Income was $190000.0 in Q4 2025, compared to $201000.0 in Q3 2025 and -$1.2 million in Q2 2025.